MENU
+Compare
ZTS
Stock ticker: NYSE
AS OF
Feb 3 closing price
Price
$122.41
Change
-$20.98 (-14.63%)
Capitalization
53.95B

ZTS ZOETIS Forecast, Technical & Fundamental Analysis

Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals... Show more

ZTS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for ZTS with price predictions
Feb 02, 2026

ZTS in upward trend: price rose above 50-day moving average on January 30, 2026

ZTS moved above its 50-day moving average on January 30, 2026 date and that indicates a change from a downward trend to an upward trend. In of 34 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 51 cases where ZTS's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on January 30, 2026. You may want to consider a long position or call options on ZTS as a result. In of 81 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The 10-day moving average for ZTS crossed bullishly above the 50-day moving average on January 06, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ZTS advanced for three days, in of 307 cases, the price rose further within the following month. The odds of a continued upward trend are .

ZTS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 266 cases where ZTS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for ZTS moved out of overbought territory on January 07, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 30 similar instances where the indicator moved out of overbought territory. In of the 30 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Moving Average Convergence Divergence Histogram (MACD) for ZTS turned negative on January 15, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 51 similar instances when the indicator turned negative. In of the 51 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ZTS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (9.990) is normal, around the industry mean (29.772). P/E Ratio (20.608) is within average values for comparable stocks, (74.035). Projected Growth (PEG Ratio) (2.298) is also within normal values, averaging (2.041). Dividend Yield (0.017) settles around the average of (0.029) among similar stocks. P/S Ratio (5.824) is also within normal values, averaging (112.501).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. ZTS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ZTS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.

View a ticker or compare two or three
ZTS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

ZTS is expected to report earnings to fall 17.65% to $1.40 per share on February 12

ZOETIS ZTS Stock Earnings Reports
Q4'25
Est.
$1.40
Q3'25
Beat
by $0.08
Q2'25
Beat
by $0.14
Q1'25
Beat
by $0.07
Q4'24
Beat
by $0.02
The last earnings report on November 04 showed earnings per share of $1.70, beating the estimate of $1.62. With 3.82M shares outstanding, the current market capitalization sits at 53.95B.
A.I.Advisor
published Dividends

ZTS is expected to pay dividends on March 03, 2026

ZOETIS ZTS Stock Dividends
A dividend of $0.53 per share will be paid with a record date of March 03, 2026, and an ex-dividend date of January 20, 2026. The last dividend of $0.50 was paid on December 02. Read more...
A.I. Advisor
published General Information

General Information

a pet medication company

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
Pharmaceuticals Generic
Address
10 Sylvan Way
Phone
+1 973 822-7000
Employees
14100
Web
https://www.zoetis.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
DTH55.240.39
+0.72%
WisdomTree International High Div ETF
ABAKF2.07N/A
N/A
ABRDN ASIA-PAC INCOME FD
OVS37.88-0.08
-0.20%
Overlay Shares Small Cap Equity ETF
HTUS39.92-0.29
-0.73%
Hull Tactical US ETF
AIQ51.04-1.34
-2.56%
Global X Artfcl Intlgc & Tech ETF

ZTS and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ZTS has been loosely correlated with ELAN. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if ZTS jumps, then ELAN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZTS
1D Price
Change %
ZTS100%
+0.10%
ELAN - ZTS
47%
Loosely correlated
+2.78%
VTRS - ZTS
37%
Loosely correlated
+4.51%
PAHC - ZTS
37%
Loosely correlated
-1.43%
AMRX - ZTS
36%
Loosely correlated
+3.73%
AMPH - ZTS
35%
Loosely correlated
+1.15%
More

Groups containing ZTS

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZTS
1D Price
Change %
ZTS100%
+0.10%
Pharmaceuticals: Generic
industry (214 stocks)
38%
Loosely correlated
+48.62%